期刊文献+

尾加压素Ⅱ与冠状动脉狭窄程度的关系研究

下载PDF
导出
摘要 目的:探讨尾加压素Ⅱ在冠状动脉病变中的作用。方法:将96例冠心病患者根据冠状动脉狭窄程度分成三组:轻度组,33例;中度组,31例;重度组,32例。采用放射免疫法检测冠状静脉窦血尾加压素Ⅱ(urotensinⅡ,UⅡ)水平,并与32例年龄和性别相当的健康体检者进行比较。结果:冠心病组冠状静脉窦血尾加压素Ⅱ显著低于对照组,而且减低程度与冠状动脉狭窄程度一致,血管重度狭窄组冠状静脉窦血尾加压素Ⅱ减低尤为明显。结论:尾加压素Ⅱ可能参与了冠状动脉粥样硬化的发病过程。
机构地区 绍兴市人民医院
出处 《心脑血管病防治》 2009年第3期183-184,共2页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
基金 绍兴市科技局科研项目(2006A33001)
  • 相关文献

参考文献4

  • 1Coulouarn Y,Lihrmann I,Jegou S,et al.Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord[J].Proc Natl Acad Sci US A,1998,95:15803-15808.
  • 2Ames R S,Sarau H M,Chambers J K,et al.Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14[J].Nature,1999,401:282-286.
  • 3方石虎,李志樑,吴宏超,唐朝枢,陆青,刘海潮,严全能.冠心病患者血浆尾加压素Ⅱ的临床研究[J].第一军医大学学报,2004,24(5):563-565. 被引量:21
  • 4涂晓文,刘映峰,李志樑,吴宏超,陆青,唐朝枢.尾加压素Ⅱ在冠状动脉中的表达与冠状动脉粥样硬化[J].第一军医大学学报,2003,23(6):572-574. 被引量:11

二级参考文献30

  • 1[1]Conlon JM, Yano K, Waugh D, et al. Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation in vertebrates[J]. J Exp Zool, 1996, 275(2-3): 226-38.
  • 2[2]Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning ofcDNA encoding the urotensin Ⅱ precursor in frog and human reveals expression of urotensin Ⅱ gene in motoneurons of the spinal cord [J]. Proc Natl Acad Sci USA, 1998, 95(26): 15803-8.
  • 3[3]Ames RS, Sarau HM, Chambers JK, et al. Human urotensin- Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J]. Nature, 1999, 401(6750): 282-6.
  • 4[5]Dschietzig T, Richter C, Bartsch C, et al. Flow-induced pressure differentially regulates endothelin-1, urotensin Ⅱ, adrenomedullin, and relaxin in pulmonary vascular endothelium [J]. BiochemBiophys Res Commun, 2001, 289(1): 245-51.
  • 5[6]Bond H, Winter MJ, Warne JM, et al. Plasma concentrations of arginine vasotocin and urotensin Ⅱ are reduced following transfer of the euryhaline flounder (Platichthys flesus) from seawater to fresh water[J]. Gan Comp Endocrinol, 2002, 125(1): 113-20.
  • 6[7]Liu Q, Pong SS, Zeng Z, et al. Identification ofurotensin Ⅱ as theendogenous ligand for the orphan G-protein-coupled receptor GPR14[J]. Biochem Biophys Res Commun, 1999, 226(1): 174-8.
  • 7[9]Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin Ⅱ: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 [ J ]. Br J Pharmacol, 2000, 131(3): 441-6.
  • 8[10]Maclean MR, Alexander D, Stirrrat A, et al. Contractile responses to human urotensin- Ⅱ in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat [J]. Br J Pharmacol, 2000, 130(2): 201-4.
  • 9[11]Douglas SA, Sulpizio AC, Piercy V, et al. Differential vasocons trictor activity of human urotensin- Ⅱ in vascular tissue isolated from the rat, mouse, dog, pig, mamoset and cynomolgus monkey [J]. BrJ Pharmacol, 2000, 131(7): 1262-74.
  • 10[12]Bohm F, Pernow J. Urotensin Ⅱ evokes potent vasoconstriction in humans in vivo[J]. Br J Pharmacol, 2002, 135(1): 25-7.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部